Vital Data Technology Blog

Agentic AI in Clinical Workflows: Reimagining the Operating Model for Healthcare Payers

Written by Vital Data Technology | May 12, 2026 9:45:49 PM

Healthcare payers are entering a pivotal moment. For decades, clinical workflows — including prior authorization, claims adjudication, appeals, and care management — have been governed by static rules engines, fragmented data, and manual review processes. The emergence of agentic AI signals a fundamental shift: from automating tasks to orchestrating intelligent, end-to-end decision-making systems.

This is not incremental innovation. It is a redefinition of how clinical and administrative intelligence is executed at scale — and, increasingly, how payer operating models are designed.

From Automation to Agency

Agentic AI represents a step beyond traditional automation. These systems can plan, reason, and execute multi-step workflows independently, adjusting decisions as clinical context, policy, and regulation evolve. The more meaningful shift, though, is organizational. Deloitte reports that over 80% of healthcare executives expect agentic and generative AI to deliver moderate-to-significant value across clinical, operational, and business functions by the end of 2026.

Even more telling, 70% of health plans are prioritizing agentic AI in utilization management, prior authorization, and claims workflows. More than 80% of organizations are targeting clinical operations and care delivery transformation. Leaders are starting to see agentic AI not as a point tool, but as a strategic lever for growth, performance, and workforce sustainability. Taken together, these signals point to a real inflection point: will agentic AI be deployed as a narrow efficiency play, or as the foundation of a new payer operating model? Deloitte frames this as a defining choice for healthcare leaders.

 

Domain-Specific Reasoning in Clinical Workflows

Agentic AI’s real impact comes from domain-aware reasoning — the ability to interpret clinical, regulatory, and operational context at the same time and keep that context “live” across an end-to-end workflow. In practice, that means an agent can read a clinical note, understand the member’s history and current risk, align that with benefits, medical policy, and CMS or state guidance, and then decide what to do next (approve, pend, request more information, or escalate) while documenting a rationale that stands up to audit and oversight.

This pushes payers beyond static rules into systems that handle nuance, respect coverage limits, anticipate downstream effects on quality and cost, and support clinicians and reviewers with clear, explainable recommendations instead of rigid pass/fail checks. The impact becomes very tangible when you look at specific workflows like prior authorization and care management.

Prior Authorization: From Gatekeeping to Intelligent Clinical Alignment

Prior authorization has long been a pressure point in payer–provider relationships. Agentic AI reframes PA by embedding clinical reasoning directly into daily operations. These systems can synthesize structured and unstructured clinical data, interpret payer policy alongside evidence-based guidelines, and orchestrate multi-step decision pathways.

Rather than relying on rigid rule matching, agentic AI reasons across context, enabling real-time approvals for routine, policy-aligned requests and clear, structured escalation paths for complex or ambiguous cases. Deloitte notes that these capabilities sit among the top priorities for health plans, underscoring their central role in operating model transformation.

Care Management: Continuous, Coordinated Intelligence

Care management is inherently longitudinal and cross-functional. Agentic AI strengthens it by maintaining continuous coordination across time, teams, and systems. It supports ongoing risk stratification using multimodal data, dynamically orchestrates care plans as member status changes, and triggers proactive outreach and intervention when risk starts to rise.

Deloitte’s research highlights the emergence of “agent ecosystems” — multiple agents working together across payer and provider networks to enable proactive, coordinated care. These ecosystems reduce knowledge silos, cut down on handoffs, and minimize delays in intervention, replacing them with continuous, intelligent orchestration that tracks directly to enterprise performance, quality, and member experience objectives.

This represents a shift from linear workflows to dynamic, multi-agent orchestration, and from isolated decisions to system-wide intelligence. The implication is significant: clinical workflows stop being static processes and become adaptive systems.

The Enterprise Imperative: Scaling Beyond Pilots

Despite the momentum, many organizations remain stuck in pilot mode. Deloitte points to a growing tension: leaders see the upside of agentic AI but struggle to move from promising experiments to production deployments in core clinical and operational workflows. The issue is seldom model performance — it is operationalization. Without the right foundation, pilots stay disconnected from production systems, value stays trapped in individual departments, and fragmented adoption creates inconsistent standards and added risk.

That is why enterprise readiness matters. Scaled impact requires shared governance, interoperable data, workflow orchestration, and clear human-in-the-loop roles. For payers, this becomes a strategic choice: keep agentic AI at the margins as a set of pilots, or make it a core capability embedded across utilization management, care management, quality, and finance.

Building the Foundation: Secure, Compliant, and Scalable

Realizing the full potential of agentic AI requires more than advanced models — it demands a strong, enterprise-grade foundation. At the base of that foundation is governance as a first-class capability. AI must be auditable, explainable, and aligned to clinical policy, with full traceability back to source data, rules, and guidelines to ensure consistency, compliance, and trust. Without this level of governance, organizations invite clinical inconsistency, regulatory exposure, and erosion of trust among clinicians, members, regulators, and boards. Deloitte and broader industry research consistently emphasize that mature governance is the prerequisite for scaling AI safely; it cannot be treated as an add-on after pilots succeed.

Built on that is data interoperability. Agentic systems depend on unified, high-quality data across claims, clinical, and care management domains—bringing together structured and unstructured context to support accurate, reliable decision-making. When that context is fragmented or incomplete, reasoning degrades, decisions become less reliable, and the business case for AI weakens. For executives, this means that investments in data quality, integration, and context management are not separate from AI strategy; they are foundational to it.

The third layer is human-in-the-loop (HITL) oversight. Agentic AI delivers the most value when it is deliberately paired with human expertise in a “shared work” model. AI should handle routine, repeatable, and policy-aligned decisions at scale, while clinicians and reviewers focus on edge cases, complex members, and scenarios where judgment, ethics, or member preference play a larger role. To support this, systems must provide transparent reasoning and clear evidence paths so humans can validate, override, or refine recommendations. This approach both safeguards clinical quality and accelerates adoption by giving leaders and frontline teams confidence that automation is augmenting, not replacing, professional judgment.

At the top sits orchestration — the layer that connects everything. This layer connects agents into end-to-end processes, supports multi-step reasoning across functions, and ensures that policies, guardrails, and metrics are applied consistently across utilization management, care management, quality, and finance.

Together, these layers form the clinical and operational foundation for scaling agentic AI — enabling health plans to move from isolated automation to coordinated, enterprise-wide decisioning.

A Strategic Crossroads for Payers

Deloitte’s research underscores a critical strategic reality: agentic AI is not just improving workflows — it is redefining the payer operating model. Healthcare leaders now face a clear choice: optimize existing processes incrementally, or re-architect how clinical and administrative work is performed. Those who treat agentic AI as a tactical tool may see meaningful efficiency gains. Those who embrace it as an operating model transformation have the opportunity to reduce friction across the care continuum, unlock new levels of clinical and financial performance, and build organizations that are more adaptive and resilient in the face of ongoing change.

Contact us to learn how Vital Data Technology is helping health plans embed agentic AI into real clinical workflows and realize significant impact at scale.